A Simplified and Rapid High-Performance Liquid Chromatographic Assay for Ketoprofen in Isopropyl Myristate

Journal of Chromatographic Science

Volumn 36, Issue 10, 1998, Pages 495-498

  Proniuk, Stefan ^a   Lerkpulsawad, Supaporn ^a   Blanchard, James ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; MYRISTIC ACID DERIVATIVE; MYRISTIC ACID ISOPROPYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; PHARMACEUTICS; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KETOPROFEN; MYRISTATES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 0032187871     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/36.10.495     Document Type: Article

References (14)

1. O. Airaksinen. Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int. J. Clin. Pharm. 31: 561-63 (1993).
2. R.O. Day, G.G. Graham, D.E. Furst, and E. Lee. Drugs for Rheumatic Disease: Ibuprofen, Fenoprofen, Ketoproten, H.E. Paulus, Ed. Churchill Livingstone Inc., New York, NY, 1987, pp 315-45.
3. R.K. Patel and P.F. Leswell. Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. Clin. Ther. 18: 497-507 (1996).
4. J. Ostrenga, C. Steinmetz, and B. Poulsen. Significance of vehicle composition I: relationship between topical vehicle composition, skin penetrability, and clinical efficacy. J. Pharm. Sci. 60: 1175-79 (1971).
5. B.J. Poulsen, E. Young, V. Coquilla, and M. Katz. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. J. Pharm. Sci. 57: 928-33 (1968).
6. P. Chen-Chow and S.G. Frank. The determination of lidocaine and benzocaine in isopropyl myristate. Int. J. Pharm. 8: 81-87 (1981).
7. S.C. Chi and H.W. Jun. Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell. J. Pharm. Sci. 80: 280-83 (1991).
8. F.P. Bonina, L. Montenegro, and F. Guerrera. Naproxen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vitro evaluation. Int. J. Pharm. 100: 99-105 (1993).
9. E.W. Smith and J.M. Haigh. In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase. Pharm. Res. 6: 431-35 (1989).
10. Phenomenex Chromatography 98/99 Catalog. Phenomenex, Torrance, CA, pp 146-47.
11. S.-C. Chi and H.W. Jun. Quantitation of ketoprofen in isopropyl myristate by high performance liquid chromatography. J. Liq. Chromatogr. 12: 2931-45 (1989).
12. Personal communication, Hanson Research Corporation, Chatsworth, CA, 1997.
13. W.J. Lough and I.W. Wainer. High Performance Liquid Chromatography: Method Development and Quantitation. Blackie Academic & Professional, Glasgow, U.K., 1996, pp 160-61.
14. V.P. Shah, J.S. Elkins, and R.L. Williams. In vitro drug release measurement for topical glucocorticoid creams. Pharmacopeial Forum 19: 5048-60 (1993).